Tango Therapeutics Inc
TNGX
NASDAQ
Biotechnology
$25.60
USD
-0.05 (-0.19%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $4.33B
Volume 1.4M
Price Target
$35.00 – $69.00
USD
The 5 analysts offering 1-year price forecasts have a max estimate of $69.00 and a min estimate of $35.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$55.20
+$23.4 vs prior
Implied Upside
+115.6%
+91.5% vs prior
Analyst Covering
5
-4 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
36%
Many ratings are older - consensus may be less current
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$4.80 Gap
Median $60.00 vs avg $55.20 - a few cautious outliers are pulling the average down
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
5 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
5 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Michael Schmidt | Guggenheim | Buy | Maintained | 4 days ago | Plus | Plus | Plus |
John Newman | Canaccord Genuity | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Maury Raycroft | Jefferies | Buy | Upgraded | 1 month ago | Plus | Plus | Plus |
Robert Burns | HC Wainwright & Co. | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Andrew Berens | Leerink Partners | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
